IGF1R and breast cancer: Furthermore, a high mRNA ratio of IGFBP-5/IGFBP-4 from patients’ tissue enhanced the power of its poor prognostic value, and also predicted resistance to the IGF-1R and INSR TKI, BMS-536924, in a breast cancer cell line (197).